CP-675,206 In Patients With Advanced Melanoma

Clinical Trial ID NCT00086489

PubWeight™ 3.86‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00086489

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanoma. J Transl Med 2008 1.56
2 Long term survival with cytotoxic T lymphocyte-associated antigen 4 blockade using tremelimumab. Eur J Cancer 2015 1.53
3 Evolving Concepts: Immunity in Oncology from Targets to Treatments. J Oncol 2015 0.81
4 Tremelimumab. Drugs R D 2010 0.75
Next 100